Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00502112
Status:
COMPLETED
Last Update Posted:
2011-10-12
First Post:
2007-07-13
Brief Title:
A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes MDS
Sponsor:
Organization:
Seagen Inc